CATHERINE LONG: Open Payments
NPI 1932828779 · SAINT JOSEPH, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$290 in 14 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $203 · 2025 $290
Food & beverage: $290
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 3 | $93 |
| AstraZeneca Pharmaceuticals LP | 5 | $79 |
| Amgen Inc. | 2 | $38 |
| Novo Nordisk Inc | 1 | $27 |
| ABBVIE INC. | 1 | $21 |
| Axsome Therapeutics, Inc. | 1 | $16 |
| Lilly USA, LLC | 1 | $16 |
Products named: REXULTI, FARXIGA, Ozempic, REPATHA, MAVYRET, AIRSUPRA, Auvelity, ZEPBOUND.
Industry payments across MO — which companies pay providers there.
